BW
ABBV icon

BXM Wealth’s AbbVie ABBV Stock Holding History

BXM Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
5,177
+1,399
+37% +$301K 0.71% 33
2026
Q1 		$822K Sell
3,778
-3,674
-49% -$815K 0.63% 40
2025
Q4 		$867K Buy
7,452
+2,502
+51% +$570K 0.67% 37
2025
Q3 		$1.15M Buy
4,950
+1,269
+34% +$258K 1.09% 23
2025
Q2 		$683K Sell
3,681
-80
-2% -$14.9K 0.81% 35
2025
Q1 		$788K Buy
3,761
+334
+10% +$64.9K 0.95% 32
2024
Q4 		$609K Buy
+3,427
New +$630K 0.85% 38

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

BXM Wealth's ABBV Position: Q2 2026 in Review

BXM Wealth increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $301K and bringing the position to 5,177 shares worth $1.3M. The position accounts for 0.71% of the portfolio, ranked #33.

BXM Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,509 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BXM Wealth held 5,177 shares of AbbVie worth $1.3M as of Q2 2026.
  • BXM Wealth bought 1,399 AbbVie shares in Q2 2026, an estimated $301K.
  • AbbVie made up 0.71% of BXM Wealth's portfolio in Q2 2026, its #33 holding.
  • BXM Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,509 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.